BackGenetec Technology Berhad Overview

Genetec Technology Berhad EBIT

Latest ebit for 0104.KL: $-120M, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$14.71M
↑ 64.55% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$122.52M
↓ 369.94% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Genetec Technology Berhad (0104.KL) FAQ

The latest EBIT for 0104.KL is $-120M as of June 2026. That compares with $-26M in the prior-year period — down 369.9% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Genetec Technology Berhad's historical trend and sector peers before judging valuation or financial health.

Over the past year, 0104.KL's EBIT moved from $-26M to $-120M — a 369.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genetec Technology Berhad's operating scale or balance-sheet position.

Against its sector companies, 0104.KL currently prints $-120M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Genetec Technology Berhad's growth, margins, and balance sheet.

A EBIT figure of $-120M for 0104.KL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 0104.KL's EBIT ($-120M), review year-over-year change from $-26M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.